CD44 and cancer: Cisplatin-resistant oral squamous cell carcinoma (OSCC) cells exhibit an enriched putative cancer stem–like signature with increased expression of CD44 and Oct-4 and enhanced sphere-forming ability, coupled with the acquisition of an EMT phenotype.